Welcome to the latest issue of The Krembil.
The Krembil is the official newsletter of the Krembil Research Institute (formerly the Toronto Western Research Institute). Research at Krembil is focused on finding innovative treatments and cures for chronic debilitating disorders, including arthritis and diseases of the brain and eyes.
Stories in this month’s issue include:
● The Don Weaver Symposium: Krembil highlights the research, impact and legacy of its former Director, Dr. Donald Weaver.
● Excellence in Health Research: Neurosurgeon and Senior Scientist Dr. Gelareh Zadeh wins the Canada Gairdner Momentum Award.
● Interrupting Interactions: Researchers identify a protein interaction involved in Parkinson’s and a way to disrupt it.
● Promising New Therapy: New treatment for glioblastoma prolongs patient survival in an early-phase clinical trial.
● Why Immune Cells Attack: New research reveals how the body generates damaging autoantibodies in lupus.
● An Unexplored Mechanism: Study identifies a key cause of abnormal neuron development in 15q13.3 microdeletion syndrome.
Read these stories here. To read previous issues, see the newsletter archive.